EpirubicinCyclophosphamideAntineoplastic Combined Chemotherapy ProtocolsDoxorubicinAntibiotics, AntineoplasticBreast NeoplasmsFluorouracilVincristineDrug Administration ScheduleAntineoplastic Agents, AlkylatingPhosphoramide MustardsMethotrexatePrednisoneTreatment OutcomeChemotherapy, AdjuvantPaclitaxelGranulocyte Colony-Stimulating FactorDisease-Free SurvivalTaxoidsEtoposideCombined Modality TherapyCisplatinImmunosuppressive AgentsLeukopeniaThiotepaDose-Response Relationship, DrugSurvival AnalysisPulse Therapy, DrugSurvival RateRazoxaneRemission InductionNeoadjuvant TherapyIfosfamideNeutropeniaInfusions, IntravenousBusulfanAnthracyclinesVinblastineLymphoma, Non-HodgkinPrednisoloneAntineoplastic AgentsAlopeciaAntibodies, Monoclonal, Murine-DerivedNeoplasm StagingDeoxycytidineVidarabineBone Marrow TransplantationHematologic DiseasesHematopoietic Stem Cell TransplantationDrug Therapy, CombinationFollow-Up StudiesMitoxantroneCarboplatinTime FactorsVomitingTransplantation, AutologousNeoplasm MetastasisMethylprednisoloneCystitisNauseaAdministration, MetronomicWhole-Body IrradiationMastectomy, RadicalCarmustineLymphatic MetastasisTransplantation ConditioningDrug EvaluationMelphalanBleomycinInjections, IntravenousPrognosisProspective StudiesImmunosuppressionAzathioprineWegener GranulomatosisHematopoietic Stem Cell MobilizationLupus NephritisReceptor, erbB-2AmenorrheaMesnaLeukocyte CountBiotransformationMaximum Tolerated DoseCarcinoma, Small CellProlyl HydroxylasesNeoplasm Recurrence, LocalChlorambucilStomatitisAcroleinAdenocarcinomaTamoxifenAntibodies, MonoclonalRecurrencePremenopauseAdministration, OralTransplantation, HomologousAlkylating AgentsDrug Resistance, NeoplasmStomach NeoplasmsVindesine